Tung‐Hung Su

9.2k total citations · 1 hit paper
188 papers, 4.0k citations indexed

About

Tung‐Hung Su is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tung‐Hung Su has authored 188 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Hepatology, 147 papers in Epidemiology and 15 papers in Infectious Diseases. Recurrent topics in Tung‐Hung Su's work include Liver Disease Diagnosis and Treatment (121 papers), Hepatitis C virus research (117 papers) and Hepatitis B Virus Studies (116 papers). Tung‐Hung Su is often cited by papers focused on Liver Disease Diagnosis and Treatment (121 papers), Hepatitis C virus research (117 papers) and Hepatitis B Virus Studies (116 papers). Tung‐Hung Su collaborates with scholars based in Taiwan, United States and Australia. Tung‐Hung Su's co-authors include Jia‐Horng Kao, Chun‐Jen Liu, Pei‐Jer Chen, Tai‐Chung Tseng, Ding‐Shinn Chen, Chen‐Hua Liu, Hung‐Chih Yang, Chi‐Ling Chen, Stephanie Fang–Tzu Kuo and Chia‐Chi Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Tung‐Hung Su

177 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load

2012 415 citations Tai‐Chung Tseng, Chun‐Jen Liu et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tung‐Hung Su Taiwan	34	3.2k	3.2k	315	291	225	188	4.0k
Hélène Fontaine France	23	3.2k 1.0×	3.0k 1.0×	312 1.0×	339 1.2×	230 1.0×	58	3.9k
Tawesak Tanwandee Thailand	26	3.6k 1.1×	3.8k 1.2×	158 0.5×	260 0.9×	205 0.9×	125	4.4k
Lung‐Yi Mak Hong Kong	31	2.3k 0.7×	1.8k 0.6×	509 1.6×	188 0.6×	254 1.1×	164	3.2k
Wan Cheng Chow Singapore	19	3.4k 1.1×	3.3k 1.1×	171 0.5×	224 0.8×	206 0.9×	48	3.9k
Danny Ka‐Ho Wong Hong Kong	47	5.4k 1.7×	5.0k 1.6×	442 1.4×	331 1.1×	236 1.0×	137	6.0k
Yasuhiro Asahina Japan	31	3.1k 1.0×	3.8k 1.2×	516 1.6×	419 1.4×	259 1.2×	129	4.5k
Tai‐Chung Tseng Taiwan	34	3.5k 1.1×	3.4k 1.1×	232 0.7×	237 0.8×	146 0.6×	166	4.1k
Zu‐Yau Lin Taiwan	37	2.8k 0.9×	3.0k 0.9×	538 1.7×	199 0.7×	315 1.4×	205	4.3k
Chih‐Lin Lin Taiwan	30	2.8k 0.9×	2.6k 0.8×	269 0.9×	133 0.5×	205 0.9×	97	3.2k
Eiji Mita Japan	32	2.0k 0.6×	2.4k 0.7×	540 1.7×	196 0.7×	263 1.2×	120	3.3k

Countries citing papers authored by Tung‐Hung Su

Since Specialization

Citations

This map shows the geographic impact of Tung‐Hung Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tung‐Hung Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tung‐Hung Su more than expected).

Fields of papers citing papers by Tung‐Hung Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tung‐Hung Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tung‐Hung Su. The network helps show where Tung‐Hung Su may publish in the future.

Co-authorship network of co-authors of Tung‐Hung Su

This figure shows the co-authorship network connecting the top 25 collaborators of Tung‐Hung Su. A scholar is included among the top collaborators of Tung‐Hung Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tung‐Hung Su. Tung‐Hung Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tseng, Tai‐Chung, Yao‐Chun Hsu, Tung‐Hung Su, et al.. (2025). Expert consensus on clinical usefulness of M2BPGi for managing chronic liver diseases. Journal of the Formosan Medical Association. 124(11). 1010–1017.

Su, Tung‐Hung, Sheng‐Shun Yang, Mei–Hsuan Lee, et al.. (2025). High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease. Clinical and Molecular Hepatology. 31(3). 796–809. 1 indexed citations

Chang, Yu‐Ping, Jia‐Horng Kao, Tung‐Hung Su, et al.. (2025). Long-term serum ferritin dynamics in patients receiving antiviral treatment for hepatitis C virus infection. Journal of the Formosan Medical Association. 125(3). 283–290. 3 indexed citations

Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2025). Higher level of HBsAg associated with delayed development of HCC in immune-tolerant patients. Hepatology. 83(1). 142–155. 1 indexed citations

Chen, Ya‐Fang, Cheng‐Hsuan Li, Ni‐Chung Lee, et al.. (2025). Plasma Glial Fibrillary Acidic Protein Correlates With Brain Metal Burden in Wilson's Disease. Annals of Clinical and Translational Neurology. 12(12). 2433–2445.

Tseng, Tai‐Chung, Shang‐Chin Huang, Chun‐Jen Liu, et al.. (2025). Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold. Gut. 74(11). 1896–1904. 1 indexed citations

Huang, Yu‐Shan, Szu‐Min Hsieh, Feng‐Chiao Tsai, et al.. (2024). Serological responses to COVID-19 vaccination in patients with chronic liver diseases. Journal of the Formosan Medical Association. 1 indexed citations

Su, Tung‐Hung, Jiawei Li, Wang-Da Liu, et al.. (2024). Telemedicine facilitates medical care for hospitalized patients in quarantine. Journal of the Formosan Medical Association. 125(1). 83–89.

Su, Tung‐Hung, et al.. (2024). Multimodal Attention Network for Dementia Prediction. IEEE Journal of Biomedical and Health Informatics. 28(11). 6918–6930. 3 indexed citations

10.

Tseng, Tai‐Chung, Chun‐Jen Liu, Chun‐Ming Hong, et al.. (2023). Low Hepatitis B Core–Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels. Gastroenterology. 164(4). 669–679.e6. 13 indexed citations

11.

Tseng, Tai‐Chung, Tetsuya Hosaka, Chun‐Jen Liu, et al.. (2023). HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negative. JHEP Reports. 6(1). 100956–100956. 5 indexed citations

12.

Lee, Ni‐Chung, Yin‐Hsiu Chien, Wuh‐Liang Hwu, et al.. (2023). Clinical Characteristics, Genetic Features, and Long-Term Outcome of Wilson’s Disease in a Taiwanese Population: An 11-Year Follow-Up Study. Journal of Movement Disorders. 16(2). 168–179. 4 indexed citations

13.

Liu, Chen‐Hua, Hsin‐Yun Sun, Cheng‐Yuan Peng, et al.. (2022). Hepatitis C Virus Reinfection in People With HIV in Taiwan After Achieving Sustained Virologic Response With Antiviral Treatment: The RECUR Study. Open Forum Infectious Diseases. 9(8). ofac348–ofac348. 10 indexed citations

14.

Liu, Chen‐Hua, Hsin‐Yun Sun, Szu‐Min Hsieh, et al.. (2021). Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus‐coinfected patients receiving sofosbuvir‐based direct‐acting antivirals and antiretroviral therapy. Journal of Viral Hepatitis. 28(6). 887–896. 6 indexed citations

15.

Tseng, Tai‐Chung, Chun‐Jen Liu, Wanting Yang, et al.. (2021). Serum hepatitis B core‐related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary Pharmacology & Therapeutics. 53(8). 908–918. 12 indexed citations

16.

Yang, Sheng‐Shun, Tung‐Hung Su, Hung‐Chih Yang, et al.. (2018). Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study. Journal of Hepatology. 68. S266–S266. 5 indexed citations

17.

Yang, Wanting, Liwei Wu, Tai‐Chung Tseng, et al.. (2016). Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine. 95(10). e2995–e2995. 14 indexed citations

18.

Liu, Chen‐Hua, Cheng‐Chao Liang, Chun‐Jen Liu, et al.. (2015). Comparison of Abbott RealTime HCV Genotype II with Versant Line Probe Assay 2.0 for Hepatitis C Virus Genotyping. Journal of Clinical Microbiology. 53(5). 1754–1757. 59 indexed citations

19.

Tseng, Tai‐Chung, Chun‐Jen Liu, Hung‐Chih Yang, et al.. (2014). Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 64(2). 292–302. 84 indexed citations

20.

Tseng, Tai‐Chung, Chun‐Jen Liu, Tung‐Hung Su, et al.. (2012). Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation. The Journal of Infectious Diseases. 206(10). 1521–1531. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact